ATXS - Astria Therapeutics 10% owner Perceptive Advisors discloses purchase of 2.48M shares February, 06 2024 12:46 PM Astria Therapeutics Inc. 2024-02-06 12:46:00 ET More on Astria TherapeuticS Astria Therapeutics: Too Much Risk, Too Little Reward Despite Near-Term Data Readout Astria Therapeutics stock jumps on pricing of $125M underwritten offering Astria TherapeuticS GAAP EPS of -$0.63 misses by $0.14 For further details see: Astria Therapeutics 10% owner Perceptive Advisors discloses purchase of 2.48M shares